Cathy Anne Pinto

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Economics, Econometrics and Finance · Social Sciences

12h-index802citations49works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(17), Patient-Provider Communication in Healthcare(8), Renal cell carcinoma treatment(7), Cancer Immunotherapy and Biomarkers(5), Economic and Environmental Valuation(5)

Publications49 total

Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease
European Urology·2025· 5 citedOpen Access
Oncologists’ and urologists’ preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment
Future Oncology·2025· 3 citedOpen Access
Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment
Future Oncology·2025· 3 citedOpen Access
Exploring the efficacy of belzutifan in the treatment of renal cell carcinoma associated with von Hippel-Lindau disease: A comparative analysis with external control arm.
Journal of Clinical Oncology·2025
A Didáctica as Leis Naturais na Disciplina de Química
2025
PCR77 Exploring Alternative Methods to Quantify Patient Preferences in Rare Neuromuscular Disorders: A Case Study of the IMI-PREFER Project
Value in Health·2024Open Access
Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey
Patient·2023· 7 citedOpen Access
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
Frontiers in Pharmacology·2023· 19 citedOpen Access
Regulatory benefit–risk assessment of oncology drugs: A systematic review of FDA and EMA approvals
Drug Discovery Today·2023· 4 cited
P38 Current Practices and Challenges When Submitting Patient Experience Data for US Regulatory Decision-Making: An Industry Survey
Value in Health·2023Open Access
Use of real-world evidence to benchmark clinical trial results: A case study in von Hippel-Lindau (VHL) disease.
Journal of Clinical Oncology·2023
MP19-15 EXPLORING PERCEPTIONS OF THE RISK OF RECURRENCE IN RENAL CELL CARCINOMA: EVIDENCE FROM A SURVEY OF PRACTICING PHYSICIANS
The Journal of Urology·2023
Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.
Journal of Clinical Oncology·2023
Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.
Journal of Clinical Oncology·2023· 1 cited
Comparing Outcomes of a Discrete Choice Experiment and Case 2 Best-Worst Scaling: An Application to Neuromuscular Disease Treatment
Patient·2023· 12 citedOpen Access
Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis
Value in Health·2022· 10 citedOpen Access
OP35 Suitability Of Preference Methods Across The Medical Product Lifecycle: A Multicriteria Decision Analysis
International Journal of Technology Assessment in Health Care·2022· 1 citedOpen Access
Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma
Acta Oncologica·2022· 6 citedOpen Access
Treatment and Overall Survival Among Anti-PD-1-Exposed Advanced Melanoma Patients with Evidence of Disease Progression
Immunotherapy·2021· 4 cited
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment
Journal of Clinical Epidemiology·2021· 2 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Esther W. de Bekker‐Grob(11), Chiara Whichello(8), Bennett Levitan(8), Isabelle Huys(7), Eline van Overbeeke(7), Cecilia Jimenez‐Moreno(6), Tommi Tervonen(6), Rodolfo F. Perini(6), Jorien Veldwijk(5), G. Ardine de Wit(5), Julie Fox(5), Shawna R. Calhoun(5), Caroline Vass(5), Kelley Myers(5), Cooper Bussberg(5), Rituparna Bhattacharya(5), Christine Poulos(5), Vikas Soekhai(4), Juhaeri Juhaeri(4), Ulrik Kihlbom(4)